Oxycyte: Phase II started

Oxygen Biotherapeutics began the double-blind, placebo-controlled, dose-escalation, Swiss Phase II STOP TBI trial to evaluate 3 dosages of IV Oxycyte in 128 patients. Swissmedic's approval of the tria...